Enhancing Blood Fluidity and Physiological Markers in Early- Stage Alzheimer’s Disease Using Biophoton Generators: A Case Study
Author(s):
Ya Hu, Leon Chien, Helen Y Gu and James Z Liu*
Background: Impaired blood fluidity and microcirculation are increasingly recognized as contributors to the pathophysiology of Alzheimer’s disease (AD).
This study investigates the effect of strong biophoton generators on blood quality, oxygenation, and cellular morphology in a patient with early-stage AD.
Methods: A 59-year-old female with clinically diagnosed early-stage AD was exposed to four biophoton generators emitting coherent biophysical fields for
≥8 hours/day over 4 weeks. Blood samples were analyzed under a dark-field microscope at Baseline, Day 3, Day 5, Day 13, Day 18, and Day 27. Physiological
markers assessed included blood viscosity, oxygen saturation, lipid profile, and cellular morphology.Results: By Day 3, blood became cleaner with reduced cell aggregation and increased oxygenation. By Day 5, further improvements in morphology and
immune activation were observed. Day 13 and Day 18, showed reduced systemic pain and better sleep initiation without hormonal support. By Day 27, the
patient displayed stabilized cell morphology, improved metabolism, and reduced dependence on medications.Conclusion: Biophoton therapy demonstrated a measurable improvement in blood fluidity, oxygen delivery, and systemic homeostasis. These changes may
support neurological stabilization and pain reduction, offering a novel adjunctive approach for early-stage Alzheimer’s disease. Further controlled studies
are warranted.
